Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 2361-2380 of 2,731 trials

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

NCT00916006

This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.

Actinic Keratosis

Peplin269 participantsStarted Jun 2009

Los Angeles, California, United States • Oceanside, California, United States • San Diego, California, United States +18 more locations

COMPLETEDPhase 2< 1 mile

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00831844

This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them.

Adult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more

National Cancer Institute (NCI)116 participantsStarted Jan 2009

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Downey, California, United States +102 more locations

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Rheumatoid Arthritis Trials in Other Cities

Feasibility Study of Auditory Brainstem Implant in Young Children

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate

Prevention of Contrast Renal Injury With Different Hydration Strategies

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

MCS in the Treatment of Lower Urinary Tract Symptoms

Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)

Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration

Clinical Investigation of Expanded Designs of a Multifocal IOL

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Other Conditions in Los Angeles